Medicare Enrolled
Dr. Theodossis Zacharis, MD
Critical Care Medicine · New Smyrna Beach, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Zacharis from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Zacharis? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Zacharis
Dr. Theodossis Zacharis is a critical care medicine in New Smyrna Beach, FL, with 19 years in practice. Based on federal Medicare data, Dr. Zacharis performed 27,005 Medicare services across 7,909 unique beneficiaries.
Between the years covered by Open Payments, Dr. Zacharis received a total of $15,248 from 57 pharmaceutical and/or device companies across 759 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in critical care medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Zacharis is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 1% volume in FL$ $15,248 industry payments
Medicare Practice Summary
Medicare Utilization ↗27,005
Medicare services
Top 1% in FL for critical care medicine
7,909
Unique beneficiaries
$35
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,421 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Dexamethasone injection (steroid) | 9,509 | $0 | $0 |
| Office visit, established patient (30-39 min) | 3,800 | $95 | $249 |
| Ceftriaxone antibiotic injection | 2,139 | $0 | $1 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 1,478 | $29 | $74 |
| Hospital follow-up visit, high complexity | 1,262 | $94 | $200 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 1,208 | $48 | $128 |
| Injection of additional new drug or substance into vein | 1,077 | $12 | $30 |
| Test to examine how well the lungs exchange gases | 989 | $42 | $110 |
| Test to determine lung volumes using sensors | 984 | $40 | $104 |
| Injection, levofloxacin, 250 mg | 755 | $1 | $3 |
| Drug injection, under skin or into muscle | 537 | $11 | $28 |
| Injection, methylprednisolone acetate, 80 mg | 513 | $9 | $26 |
| Hospital follow-up visit, moderate complexity | 427 | $62 | $140 |
| Injection, ertapenem sodium, 500 mg | 365 | $11 | $111 |
| New patient office visit (45-59 min) | 343 | $127 | $328 |
| Critical care, first 30-74 min | 193 | $170 | $546 |
| Evaluation of use of breathing device | 191 | $13 | $33 |
| Flu vaccine administration | 169 | $30 | $36 |
| Initial hospital admission, high complexity | 143 | $137 | $387 |
| Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | 125 | $33 | $66 |
| Sleep study in sleep lab (6 years or older) | 105 | $456 | $1,150 |
| Therapy procedure using a positive pressure ventilator | 96 | $48 | $124 |
| Initial hospital admission, moderate complexity | 87 | $103 | $265 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 85 | $479 | $1,202 |
| Injection, furosemide, up to 20 mg | 67 | $0 | $2 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 64 | $40 | $106 |
| Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | 60 | $32 | $82 |
| Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | 60 | $65 | $450 |
| Flu vaccine, quadrivalent | 48 | $76 | $144 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 46 | $16 | $40 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 23 | $105 | $264 |
| Blood draw (venipuncture) | 17 | $6 | $6 |
| Administration of vaccine | 15 | $15 | $32 |
| Office visit, established patient, complex (40-54 min) | 13 | $140 | $358 |
| Office visit, established patient (20-29 min) | 12 | $64 | $176 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
4.6% high complexity
55.4% medium
40.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$15,248
Total received (2018-2024)
Avg $2,178/year across 7 years
Top 12% in FL for critical care medicine
57
Companies
759
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,153 (86.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,095 (13.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,745
2023$2,107
2022$2,357
2021$1,830
2020$1,115
2019$3,887
2018$2,207
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$2,619
GlaxoSmithKline, LLC.
$2,218
ViiV Healthcare Company
$1,600
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,362
Regeneron Healthcare Solutions, Inc.
$862
Mylan Specialty L.P.
$791
GENZYME CORPORATION
$692
JAZZ PHARMACEUTICALS INC.
$664
Philips Electronics North America Corporation
$467
Grifols USA, LLC
$339
Genentech USA, Inc.
$225
Insmed, Inc.
$216
Allergan Inc.
$198
Electromed, Inc.
$189
Amgen Inc.
$188
Novartis Pharmaceuticals Corporation
$185
Inogen, Inc.
$178
Merck Sharp & Dohme Corporation
$177
bioMerieux
$173
Actelion Pharmaceuticals US, Inc.
$170
Sunovion Pharmaceuticals Inc.
$164
PFIZER INC.
$129
CSL Behring
$110
Jazz Pharmaceuticals Inc.
$101
SANOFI-AVENTIS U.S. LLC
$82
INOGEN, INC.
$78
Takeda Pharmaceuticals U.S.A., Inc.
$71
Merck Sharp & Dohme LLC
$62
Harmony Biosciences LLC
$61
Fisher & Paykel Healthcare Inc
$60
AbbVie Inc.
$51
Teva Pharmaceuticals USA, Inc.
$47
Theravance Biopharma, Inc.
$47
Paratek Pharmaceuticals, Inc.
$47
Novo Nordisk Inc
$47
ABBVIE INC.
$45
Avadel CNS Pharmaceuticals, LLC
$37
Shire North American Group Inc
$37
Axsome Therapeutics, Inc.
$36
Melinta Therapeutics, LLC
$33
La Jolla Pharmaceutical Company
$32
EMD Serono, Inc.
$32
Philips North America LLC
$30
Eisai Inc.
$29
Allergan, Inc.
$29
E.R. Squibb & Sons, L.L.C.
$27
Boston Scientific Corporation
$25
ZOLL Respicardia, Inc.
$23
Microtransponder, Inc.
$23
Astellas Pharma US Inc
$21
Resmed Corp
$20
EISAI INC.
$19
Biogen, Inc.
$17
3B Medical, Inc.
$17
Janssen Pharmaceuticals, Inc
$16
Nabriva Therapeutics, plc
$15
Hikma Pharmaceuticals USA
$14
Top 3 companies account for 42.2% of total payments
Associated products mentioned in payments ›
(8744) Trilogy Evo · (8874) InCourage · (8874) inCourage · (AK6) Vest Therapy · ADUHELM · AIMOVIG · AIRSENSE · AIRSUPRA · ALAIR · ANORO · AVYCAZ · AirDuo Digihaler · Arikayce · BELSOMRA · BEVESPI AEROSPHERE · BOTOX · BREO · BREZTRI · BREZTRI AEROSPHERE · Baxdela · COMBIVENT RESPIMAT · COSENTYX · CUVITRU · DIFICID · DUPIXENT · Dayvigo · Dymista · ELIQUIS · EVENITY · EVUSHELD · Esbriet · FARXIGA · FASENRA · FISHER & PAYKEL HEALTHCARE · Fycompa · GIAPREZA · GLASSIA · Gamunex-C · Hizentra · IMFINZI · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · InogenOne · JANUVIA · JARDIANCE · KEYTRUDA · LONHALA MAGNAIR · LUMRYZ · LUNA · MYCAMINE · NUCALA · NUZYRA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · Obstructive Sleep Apnea Device or Hospital Respiratory Equipment · PANZYGA · Prolastin-C · Prolastin-C Liquid · Prolia · Repatha · Respiratoriy Care Undiv · Ryaltris · SHINGRIX · SMARTVEST · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Sunosi · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · Trilogy 100 · UTIBRON NEOHALER · Utibron · VIBATIV · VIDAS BRAHMS PCT · Victoza · Wakix · XARELTO · XOLAIR · XYREM · XYWAV · Xenleta · Xolair · Xyrem · YUPELRI · Yupelri · ZEPOSIA · ZERBAXA · inCourage · remede System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (86%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $56 per 100 Medicare services performed
Geographic Context
Critical Care Medicines within 10 mi
20
Per 100K population
3.5
County median income
$66,581
Nearest hospital
HALIFAX HEALTH MEDICAL CENTER
13.7 mi
13.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Zacharis is a clinical cardiology specialist, with above-average Medicare volume (top 1% in FL), and high industry engagement (low-engagement, top 12%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Zacharis experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Zacharis performed 9,509 dexamethasone injection (steroid) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Zacharis receive payments from pharmaceutical companies?
Yes. Dr. Zacharis received a total of $15,248 from 57 companies across 759 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Zacharis's costs compare to other critical care medicines in New Smyrna Beach?
Dr. Zacharis's average Medicare payment per service is $35. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Zacharis) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Critical Care Medicines in New Smyrna Beach
Browse critical care medicines in New Smyrna Beach ranked by procedure volume and transparency data.
Highest volume
Top Critical Care Medicines in FL
Critical Care Medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Critical Care Medicines in FL
Which FL critical care medicines receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC..
By company
ViiV Healthcare Company Payments to Doctors
See all physicians who received payments from ViiV Healthcare Company.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology